Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v3-EN
Language French English
Date Updated 2020-05-26 2020-05-02
Drug Identification Number 02238400 02238400
Brand name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%
Common or Proper name Phenylephrine Hydrochloride Injection USP Phenylephrine Hydrochloride Injection USP
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients PHENYLEPHRINE HYDROCHLORIDE PHENYLEPHRINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 1mL vial / fiole 10 x 1mL vial / fiole
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-01 2020-05-01
Estimated end date 2020-06-30 2020-06-30
Actual end date 2020-05-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments